Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Verneris

Showing results (91-100 of 180) with videos related to

Pageof 18
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2014
Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapyJeffrey S Miller, Cliona M Rooney, Julie Curtsinger, et al.
Transplantation and Cellular Therapy|October 10, 2023
Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic LeukemiaKevin O McNerney, Amy Moskop, Lena E Winestone, et al.
Blood|March 30, 2017
Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse modelsKeina M C Dourado, June Baik, Vanessa K P Oliveira, et al.
Haematologica|March 26, 2026
HLA-DR expression at diagnosis is not predictive of relapse risk post allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a report from the Children's Oncology GroupVasant Chinnabhandar, Michael R Verneris, Kirk R Schultz, et al.
Molecular Cancer Therapeutics|October 19, 2012
Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine productionMichelle K Gleason, Michael R Verneris, Deborah A Todhunter, et al.
Current Topics in Microbiology and Immunology|June 4, 2015
The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive TransferFrank Cichocki, Michael R Verneris, Sarah Cooley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 20, 2019
Donor HLA-E Status Associates with Disease-Free Survival and Transplant-Related Mortality after Non In Vivo T Cell-Depleted HSCT for Acute LeukemiaChrysanthi Tsamadou, Daniel Fürst, Tao Wang, et al.
European Journal of Immunology|June 6, 2015
Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferationYong-Oon Ahn, Matthew A Weeres, Marie-Luise Neulen, et al.
Science Immunology|November 21, 2020
Human innate lymphoid cell precursors express CD48 that modulates ILC differentiation through 2B4 signalingDejene M Tufa, Ashley M Yingst, George Devon Trahan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2009
Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantationJill C Beck, John E Wagner, Todd E DeFor, et al.
Pageof 18

Showing results (91-100 of 180) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2014
Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapyJeffrey S Miller, Cliona M Rooney, Julie Curtsinger, et al.
Transplantation and Cellular Therapy|October 10, 2023
Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic LeukemiaKevin O McNerney, Amy Moskop, Lena E Winestone, et al.
Blood|March 30, 2017
Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse modelsKeina M C Dourado, June Baik, Vanessa K P Oliveira, et al.
Haematologica|March 26, 2026
HLA-DR expression at diagnosis is not predictive of relapse risk post allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a report from the Children's Oncology GroupVasant Chinnabhandar, Michael R Verneris, Kirk R Schultz, et al.
Molecular Cancer Therapeutics|October 19, 2012
Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine productionMichelle K Gleason, Michael R Verneris, Deborah A Todhunter, et al.
Current Topics in Microbiology and Immunology|June 4, 2015
The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive TransferFrank Cichocki, Michael R Verneris, Sarah Cooley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 20, 2019
Donor HLA-E Status Associates with Disease-Free Survival and Transplant-Related Mortality after Non In Vivo T Cell-Depleted HSCT for Acute LeukemiaChrysanthi Tsamadou, Daniel Fürst, Tao Wang, et al.
European Journal of Immunology|June 6, 2015
Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferationYong-Oon Ahn, Matthew A Weeres, Marie-Luise Neulen, et al.
Science Immunology|November 21, 2020
Human innate lymphoid cell precursors express CD48 that modulates ILC differentiation through 2B4 signalingDejene M Tufa, Ashley M Yingst, George Devon Trahan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2009
Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantationJill C Beck, John E Wagner, Todd E DeFor, et al.
Pageof 18